Study outline At the beginning of the study, the subjects were evaluated regarding their scalp and hair loss status by a dermatologist
It received an FDA warning letter in September 2025 for misleading compounded semaglutide marketing claims, launched a compounded semaglutide pill in February 2026 that was referred to the DOJ within days and pulled within 48 hours, was sued by Novo Nordisk for patent infringement, and then reached a deal with Novo Nordisk in March 2026 to offer branded Ozempic directly through the platform
Whether youre looking to avoid medications like Ozempic or Wegovy, or youre simply seeking a gentler, long-term approach, were here with real solutions
DAILY HAIR & SCALP CARE: Apply 3 to 5 sprays to a clean, dry scalp and massage in for 30 to 60 seconds, morning and night
The Wegovy pill is not the only option at Hims & Hers, but the platform promotes it as the default first recommendation
Victoza (active ingredient:liraglutide) subcutaneous injection Initial FDA Approval: 2010 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting